Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Bio-Rad Introduces CFX Opus Deepwell Real-Time PCR Detection System
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect […]
Centerline Biomedical Raises $33 Million in Series B Financing
Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series […]
Englewood Health Introduces Robot-Assisted Spine Surgery with GPS-like Precision to New Jersey
Englewood Health has become the first hospital in New Jersey and one of only 20 hospitals in […]
Degron Therapeutics Co-Founder Provides New Strategy for Molecular Glue in Tumor Immunotherapy
Degron Therapeutics (“Degron”), a biotechnology company developing a new class of small-molecule medicines that target […]
Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma
Antengene Corporation Limited (“Antengene“ SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, […]
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and […]
Concentric by Ginkgo Crosses 10 Million Samples Tested and Expands Testing and Sequencing Capabilities to Detect Monkeypox and Other Pathogens, as Part of Scaling Its Global Biosecurity Infrastructure
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to further […]
GSK Announces £1 Billion R&D Investment Over Ten Years to Get Ahead of Infectious Diseases in Lower-income Countries
GSK plc (LSE/NYSE: GSK) announced today an investment of £1bn over ten years to accelerate […]
GSK Presents Promising New Data for Bepirovirsen, an Investigational Treatment for Chronic Hepatitis B
GSK plc today announced promising interim results from the B-Clear phase IIb trial showing that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more